Literature DB >> 2121297

Amplified expression of three jun family members inhibits erythroleukemia differentiation.

E V Prochownik1, M J Smith, K Snyder, D Emeagwali.   

Abstract

Several different proto-oncogenes have been shown to influence cellular differentiation. One of the most widely studied model systems has been the Friend murine erythroleukemia cell (F-MELC) line, which can be induced to undergo erythroid differentiation by a variety of chemical agents. Constitutive overexpression of either the c-myc or c-myb proto-oncogenes has been previously shown to inhibit F-MELC differentiation, whereas c-myc antisense sequences accelerate the process. To investigate the potential involvement of other proto-oncogenes and immediate early response genes in F-MELC differentiation, we studied the expression of the three known members of the jun family as well as another gene, egr-1, which, like the jun family members, is expressed as an immediate early response gene in growth factor-stimulated quiescent cells. All four genes were expressed in F-MELC, although the levels of expression and modes of regulation differed. Transfection with amplifiable c-jun, junB, or junD expression plasmids inhibited differentiation, whereas transfection with an egr-1 expression plasmid was without effect. These results indicate that jun family members play a role in mediating F-MELC differentiation. The known inhibitory effect of phorbol ester tumor promoters on F-MELC differentiation may be the result of their known stimulation of jun expression.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2121297

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  8 in total

1.  Ion channels in human erythroblasts. Modulation by erythropoietin.

Authors:  J Y Cheung; M B Elensky; U Brauneis; R C Scaduto; L L Bell; D L Tillotson; B A Miller
Journal:  J Clin Invest       Date:  1992-11       Impact factor: 14.808

2.  Depletion of c-myc with specific antisense sequences reverses the transformed phenotype in ras oncogene-transformed NIH 3T3 cells.

Authors:  M D Sklar; E Thompson; M J Welsh; M Liebert; J Harney; H B Grossman; M Smith; E V Prochownik
Journal:  Mol Cell Biol       Date:  1991-07       Impact factor: 4.272

3.  v-jun cooperates with v-erbB to transform the thrombocytic/megakaryocytic lineage.

Authors:  M Garcia; J Samarut
Journal:  Proc Natl Acad Sci U S A       Date:  1993-10-01       Impact factor: 11.205

4.  Jun blockade of erythropoiesis: role for repression of GATA-1 by HERP2.

Authors:  Kamaleldin E Elagib; Mang Xiao; Isa M Hussaini; Lorrie L Delehanty; Lisa A Palmer; Frederick K Racke; Michael J Birrer; Shanmugasundaram Ganapathy-Kanniappan; Ganapath Shanmugasundaram; Michael A McDevitt; Adam N Goldfarb
Journal:  Mol Cell Biol       Date:  2004-09       Impact factor: 4.272

5.  Small Maf proteins heterodimerize with Fos and may act as competitive repressors of the NF-E2 transcription factor.

Authors:  K Kataoka; K Igarashi; K Itoh; K T Fujiwara; M Noda; M Yamamoto; M Nishizawa
Journal:  Mol Cell Biol       Date:  1995-04       Impact factor: 4.272

6.  Epstein-Barr virus latent membrane protein 2A regulates c-Jun protein through extracellular signal-regulated kinase.

Authors:  Shao-Yin Chen; Jean Lu; Yin-Chu Shih; Ching-Hwa Tsai
Journal:  J Virol       Date:  2002-09       Impact factor: 5.103

Review 7.  Epstein-Barr Virus-Associated Malignancies: Roles of Viral Oncoproteins in Carcinogenesis.

Authors:  Ahmed El-Sharkawy; Lobna Al Zaidan; Ahmed Malki
Journal:  Front Oncol       Date:  2018-08-02       Impact factor: 6.244

8.  Inhibition of miR-148a-3p resists hepatocellular carcinoma progress of hepatitis C virus infection through suppressing c-Jun and MAPK pathway.

Authors:  Yibin Deng; Jianchu Wang; Meijin Huang; Guidan Xu; Wujun Wei; Houji Qin
Journal:  J Cell Mol Med       Date:  2018-12-18       Impact factor: 5.310

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.